dose of retatrutide Dosing: Early Clinical Trial Insights on How It Might Work Understanding the Retatrutide starting dose

GLP-1 receptor agonists available in the UK include several medications, each with distinct dosing schedules and strengths

All three are injectable incretin-based therapies

Right now, joining the TRIUMPH trials is the main legal route to access it in Canada, and the trial sites are listed at clinicaltrials.gov

In adults with obesity and knee osteoarthritis, retatrutide delivered: 9mg dose: 26.4% body weight reduction at 68 weeks 12mg dose: 28.7% body weight reduction at 68 weeks (average of 71.2 pounds lost) Placebo: 2.1% body weight reduction The 68-week timeframe is longer than the Phase 2 trial, which partially explains the higher numbers